4 news items
Merck Ends Keytruda Combo Melanoma Study Due to Futility
ANIP
LGND
MRK
14 May 24
monotherapy and combination studies. Merck is also working on different strategies to drive the long-term growth of Keytruda. These include innovative
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
the leadership of Scott Plesha as Chief Executive Officer. Pelthos is focused on the commercialization of innovative, safe, and efficacious therapeutic products
Ligand Pharmaceuticals Announces Launch Of Pelthos Therapeutics To Accelerate Commercialization Of ZELSUVMI, Scott Plesha Named CEO
LGND
3 Apr 24
is committed to commercializing innovative, safe, and efficacious therapeutic products to help patients impacted by diseases with limited treatment options
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMIâ„¢
LGND
3 Apr 24
(Photo: Business Wire)
Pelthos is committed to commercializing innovative, safe, and efficacious
- Prev
- 1
- Next